Anbio Biotechnology Class A Ordinary Shares Capital Reinvestment Ratio
Anbio Biotechnology Class A Ordinary Shares capital reinvestment ratio. Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($1.60 Million) in capital expenditures ($1.67). Check NNNN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Anbio Biotechnology Class A Ordinary Shares (2022–2022)
Capital reinvestment ratio of Anbio Biotechnology Class A Ordinary Shares from 2022 to 2022. This chart tracks Anbio Biotechnology Class A Ordinary Shares's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Anbio Biotechnology Class A Ordinary Sha growing its equity to track the company's year-over-year net asset growth rate.
Anbio Biotechnology Class A Ordinary Shares Capital Reinvestment Ratio by Year (2022–2022)
Anbio Biotechnology Class A Ordinary Shares capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see Anbio Biotechnology Class A Ordinary Sha (NNNN) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $4.45 Million | $2.88 | — |